These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 3922124

  • 1. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J, Niebauer B, Woloszczuk W, Frühwald F, Kolbe H.
    Wien Klin Wochenschr; 1985 Mar 29; 97(7):311-5. PubMed ID: 3922124
    [Abstract] [Full Text] [Related]

  • 2. Long-term therapy of Paget's disease of bone with EHDP.
    Siris ES, Canfield RE, Jacobs TP, Baquiran DC.
    Arthritis Rheum; 1980 Oct 29; 23(10):1177-84. PubMed ID: 6775644
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A, Gennari C, Guideri R, Vattimo A, Nardi P.
    Minerva Med; 1976 Jan 07; 67(1):1-15. PubMed ID: 814505
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C, Chapuy MC, Bressot C, Vignon E, Arlot M, Mathieu L, Edouard C, Johnston CC, Meunier PJ.
    Nouv Presse Med; 1980 Nov 29; 9(45):3429-33. PubMed ID: 6777752
    [Abstract] [Full Text] [Related]

  • 6. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S.
    Wien Med Wochenschr; 1986 Nov 30; 136(21-22):583-5. PubMed ID: 3103338
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of etidronate (EHDP) in Paget's disease of bone.
    Johnston CC, Khairi MR, Meunier PJ.
    Arthritis Rheum; 1980 Oct 30; 23(10):1172-6. PubMed ID: 6775643
    [Abstract] [Full Text] [Related]

  • 13. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD, Johnston CC, Khairi MR, Wellman H, Serafini AN, Sankey RR.
    N Engl J Med; 1973 Dec 27; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Human calcitonin in the treatment of symptomatic Paget's disease].
    Mathä R, Kovarik J, Woloszczuk W, Plenk H, Willvonseder R, Böhler N, Seidl G, Höfer R.
    Aktuelle Gerontol; 1983 Jan 27; 13(1):10-4. PubMed ID: 6131616
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
    Khairi MR, Altman RD, DeRosa GP, Zimmermann J, Schenk RK, Johnston CC.
    Ann Intern Med; 1977 Dec 27; 87(6):656-63. PubMed ID: 412450
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
    O'Donoghue DJ, Hosking DJ.
    Bone; 1987 Dec 27; 8(4):219-25. PubMed ID: 3128315
    [Abstract] [Full Text] [Related]

  • 20. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R, Russell RG, Bishop MC, Woods CG, Bishop M.
    Q J Med; 1973 Apr 27; 42(166):235-56. PubMed ID: 4206518
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.